Private Placements, Capital Formation,
Restructuring & Recapitalizations



SCOLR, Inc. ~ $5,300,00 ~ June 2003

SCOLR, Inc. is a biopharmaceutical company with proprietary, patented technologies and products operating in drug delivery and nutraceuticals markets. The Company’s novel Controlled Delivery Technology CDT™ for oral drug dosage is simple to manufacture and offers flexible dosage release suitable for a variety of markets (e.g. over-the-counter, prescription drugs and dietary supplements). Needing capital to expand the development of the CDT™, SCOLR turned to Taglich Brothers to help raise the capital from institutional and accredited individual investors with long-term horizons. Through a cost efficient Regulation D Private Placement, Taglich Brothers was able to structure a deal that was advantages to both the Company and investors.

The information contained herein does not constitute a solicitation of any order to buy or sell any securities. The information provided herein may be displayed and printed for your personal, noncommercial use only. You may not reproduce, retransmit, distribute, disseminate, sell, publish, broadcast or circulate the information to anyone, without the express written consent of Taglich Brothers, Inc.